• 제목/요약/키워드: nodules

검색결과 1,178건 처리시간 0.025초

Hederagenin의 뼈 형성 관련 작용 기전 연구 (Molecular mechanisms of hederagenin in bone formation)

  • 서현주;권인숙;권재희;심예진;조영은
    • Journal of Nutrition and Health
    • /
    • 제55권6호
    • /
    • pp.617-629
    • /
    • 2022
  • 본 연구는 속단으로부터 단일 화합물로 분리한 Hed의 조골세포 활성 효능과 작용 기전 규명을 위해 수행되었다. Hed는 MC3T3-E1 세포의 증식과 ALP 효소 활성을 자극하여 세포외 기질에 인산과 칼슘 이온 침착을 증가시켰다. Hed는 BMP-2/Smad 신호 전달 경로를 활성화하여 Runx2, ALP, OPN 및 ProCOL의 mRNA와 단백질 발현을 유의하게 증가시켜 조골세포의 성숙과 분화를 유도하였다. 따라서 본 연구결과 Hed는 조골세포 활성 효능을 가진 것으로 판단되며 항골다공증 기능성 소재로의 개발 가능성을 확인하였다.

신생아에서 비경구적 칼슘 글루코네이트 요법 이후의 의인성 피부 석회침착증 후 자연관해 (Spontaneous Resolution of Iatrogenic Calcinosis Cutis after Parenteral Calcium Gluconate Therapy in Neonates)

  • 송광순;이시욱;김두한;민경근;연창진
    • 대한정형외과학회지
    • /
    • 제54권2호
    • /
    • pp.192-196
    • /
    • 2019
  • 저칼슘혈증은 신생아에서 흔하게 발견되며 대개 정맥 내 칼슘 투여를 통해 교정할 수 있다. 이 과정에서 발생할 수 있는 의인성 피부 석회화증은 칼슘 제제의 정맥 투여에 기인하는 것으로 알려져 있다. 저자들은 칼슘 글루코네이트의 혈관 외 유출로 인하여 신생아의 상지나 하지를 침범한 피부 석회화증 3예를 보고하고자 한다. 신생아 집중치료실에서 칼슘 글루코네이트의 정맥 내 투여와 관련하여 발생한 경화성 피부 결절을 보이는 생후 2주 여아, 생후 4주 남아 및 여아, 총 3명의 신생아가 협진 의뢰되었다. 초기 발견 후 각각 3주, 4주, 6개월에 방사선 사진 및 신체 검진상 만져지는 결절과 석회화의 완전한 관해가 이루어졌다. 또한 3명 모두에게서 점진적인 치유양상을 보였으며 기능적, 미용적 합병증은 발생하지 않았다. 환자들의 일반 양성 질환에 대한 인식이 높아짐에 따라 의인성 피부 석회침착증의 조기 진단을 내리고, 질환에 대한 충분한 설명과 이해를 바탕으로 불필요한 치료를 피함으로써 의료 과실 분쟁을 줄일 수 있을 것으로 생각된다.

간전이를 동반한 대장 상피모양혈관육종: 증례 보고 (Primary Colonic Epithelioid Angiosarcoma with Hepatic Metastasis: A Case Report)

  • 임지윤;홍성숙;황지영;김현주;진소영
    • 대한영상의학회지
    • /
    • 제83권2호
    • /
    • pp.432-438
    • /
    • 2022
  • 대장 혈관육종은 매우 드문 악성 종양이며 빠르게 진행하고 나쁜 예후를 보인다. 우리는 장 폐쇄를 일으킨 대장 상피모양혈관육종의 빠르게 진행한 간전이가 있었던 44세 여자 환자의 사례를 경험하여 이를 보고하고자 한다. 복부 CT에서 불균질하게 조영증강되는 상행결장의 종괴로 인한 근위부 장 확장 소견이 있었고 수술 후 병리적으로 저분화암종으로 보고되었다. 4개월 후 추적 간 MRI에서 테두리 및 결절성의 현저한 동맥기 조영증강을 보이는 수많은 작은 간 결절들이 새로 생겼으며 간 혈관육종이 의심되는 형태로 보였다. 추가 면역조직화학검사 병리적 이차 의견에서 대장 상피모양혈관육종이 진단되었다. 환자는 6개월 후 추적 복부 CT에서 빠른 진행성 간 전이를 보였으며 8개월 후 사망하였다. 빠른 진행을 보이는 혈관육종의 간 전이의 영상 소견을 통해 혈관육종을 의심하고 재진단할 수 있었던 드문 대장 혈관육종의 교훈적인 사례로 생각된다.

후천성 면역 결핍 바이러스와 연관된 위장관 카포시 육종: 증례 보고 (Human Immunodeficiency Virus-Associated Gastrointestinal Kaposi's Sarcoma: A Case Report )

  • 임희중;박소현;최승준;박수영;이희영;정준원;정동해
    • 대한영상의학회지
    • /
    • 제81권5호
    • /
    • pp.1260-1265
    • /
    • 2020
  • 카포시 육종은 후천성 면역 결핍 증후군(acquired immunodeficiency syndrome; 이하 AIDS)와 연관되어, 피부, 점막과 여러 장기를 침범하는 다발성의 혈관성 결절로 나타나는 신생물을 일컫는다. AIDS와 연관되어 생기는 위장관 카포시 육종은 내장에 파종성 질환으로 가장 흔하게 발생한다. 우리는 다양한 장기를 침범하여 복통과 함께 장관 내 출혈을 유발한 드문 카포시 육종의 영상 소견에 대해 보고한다. 회장 대장내시경을 통해 말단 회장, S자 결장, 직장 내 다양한 병변이 발견되었으며 소장 투시검사로 공장과 회장의 병변을 확인할 수 있었다. 복부 골반 전산화단층촬영에서 회장 내 조영증강된 다양한 납작한 병변과 복강 내 크기가 커진 림프절을 발견하였다. 조직병리학 검사에서 카포시 육종으로 최종 진단이 된 환자는 항레트로바이러스제로 치료를 시행 받았다. 최근 AIDS 환자의 수가 늘고 있는 상황에서, AIDS와 연관된 Kaposi's sarcoma의 영상학적 소견을 숙지하는 것은 영상의학과 의사를 비롯한 임상의사들에게 빠른 진단과 치료뿐만이 아니라 예상치 못한 AIDS의 감염 위험에 노출될 수 있는 의료진의 안전을 위해서도 필수적이다.

Diagnosing Hepatocellular Carcinoma Using Sonazoid Contrast-Enhanced Ultrasonography: 2023 Guidelines From the Korean Society of Radiology and the Korean Society of Abdominal Radiology

  • Woo Kyoung Jeong;Hyo-Jin Kang;Sang Hyun Choi;Mi-Suk Park;Mi Hye Yu;Bohyun Kim;Myung-Won You;Sanghyeok Lim;Young Seo Cho;Min Woo Lee;Jeong Ah Hwang;Jae Young Lee;Jung Hoon Kim;Ijin Joo;Jae Seok Bae;So Yeon Kim;Yong Eun Chung;Dong Hwan Kim;Jeong Min Lee
    • Korean Journal of Radiology
    • /
    • 제24권6호
    • /
    • pp.482-497
    • /
    • 2023
  • Sonazoid, a second-generation ultrasound contrast agent, was introduced for the diagnosis of hepatic nodules. To clarify the issues with Sonazoid contrast-enhanced ultrasonography for the diagnosis of hepatocellular carcinoma (HCC), the Korean Society of Radiology and Korean Society of Abdominal Radiology collaborated on the guidelines. The guidelines are de novo, evidence-based, and selected using an electronic voting system for consensus. These include imaging protocols, diagnostic criteria for HCC, diagnostic value for lesions that are inconclusive on other imaging results, differentiation from non-HCC malignancies, surveillance of HCC, and treatment response after locoregional and systemic treatment for HCC.

Targetoid Primary Liver Malignancy in Chronic Liver Disease: Prediction of Postoperative Survival Using Preoperative MRI Findings and Clinical Factors

  • So Hyun Park;Subin Heo;Bohyun Kim;Jungbok Lee;Ho Joong Choi;Pil Soo Sung;Joon-Il Choi
    • Korean Journal of Radiology
    • /
    • 제24권3호
    • /
    • pp.190-203
    • /
    • 2023
  • Objective: We aimed to assess and validate the radiologic and clinical factors that were associated with recurrence and survival after curative surgery for heterogeneous targetoid primary liver malignancies in patients with chronic liver disease and to develop scoring systems for risk stratification. Materials and Methods: This multicenter retrospective study included 197 consecutive patients with chronic liver disease who had a single targetoid primary liver malignancy (142 hepatocellular carcinomas, 37 cholangiocarcinomas, 17 combined hepatocellular carcinoma-cholangiocarcinomas, and one neuroendocrine carcinoma) identified on preoperative gadoxetic acid-enhanced MRI and subsequently surgically removed between 2010 and 2017. Of these, 120 patients constituted the development cohort, and 77 patients from separate institution served as an external validation cohort. Factors associated with recurrence-free survival (RFS) and overall survival (OS) were identified using a Cox proportional hazards analysis, and risk scores were developed. The discriminatory power of the risk scores in the external validation cohort was evaluated using the Harrell C-index. The Kaplan-Meier curves were used to estimate RFS and OS for the different risk-score groups. Results: In RFS model 1, which eliminated features exclusively accessible on the hepatobiliary phase (HBP), tumor size of 2-5 cm or > 5 cm, and thin-rim arterial phase hyperenhancement (APHE) were included. In RFS model 2, tumors with a size of > 5 cm, tumor in vein (TIV), and HBP hypointense nodules without APHE were included. The OS model included a tumor size of > 5 cm, thin-rim APHE, TIV, and tumor vascular involvement other than TIV. The risk scores of the models showed good discriminatory performance in the external validation set (C-index, 0.62-0.76). The scoring system categorized the patients into three risk groups: favorable, intermediate, and poor, each with a distinct survival outcome (all log-rank p < 0.05). Conclusion: Risk scores based on rim arterial enhancement pattern, tumor size, HBP findings, and radiologic vascular invasion status may help predict postoperative RFS and OS in patients with targetoid primary liver malignancies.

Diagnostic Performance of Core Needle Biopsy for Characterizing Thyroidectomy Bed Lesions

  • So Yeong Jeong;Jung Hwan Baek;Sae Rom Chung;Young Jun Choi;Dong Eun Song;Ki-Wook Chung;Won Woong Kim;Jeong Hyun Lee
    • Korean Journal of Radiology
    • /
    • 제23권10호
    • /
    • pp.1019-1027
    • /
    • 2022
  • Objective: Thyroidectomy bed lesions frequently show suspicious ultrasound (US) features after thyroid surgery. Fine-needle aspiration (FNA) may not provide definitive pathological information about the lesions. Although core-needle biopsy (CNB) has excellent diagnostic performance in characterizing suspicious thyroid nodules, no published studies have evaluated the performance of CNB specifically for thyroidectomy bed lesions. Therefore, we aimed to evaluate the diagnostic performance and safety of CNB for characterizing thyroidectomy bed lesions. Materials and Methods: A total of 124 thyroidectomy bed lesions in 113 patients (79 female and 34 male; age, 23-85 years) who underwent US-guided CNB between December 2008 and December 2020 were included. We reviewed the US imaging features of the target lesions and the histories of previous biopsies. The pathologic results, diagnostic performance for malignancy, and complications of CNB were analyzed. Results: All samples (100%) obtained by CNB were adequate for pathological analysis. Pathological analysis revealed inconclusive results in two lesions (1.6%). According to the reference standard, 50 lesions were ultimately malignant (40.3%), and 72 were benign (58.1%), excluding the two inconclusive lesions. The performance of CNB for diagnosing malignant thyroidectomy bed lesions in the 122 lesions had a sensitivity of 98.0% (49/50), a specificity of 100% (72/72), positive predictive value of 100% (49/49), and negative predictive value of 98.6% (72/73). Eleven lesions were referred for CNB after prior inconclusive FNA results in thyroidectomy bed lesions, for all of which CNB yielded correct conclusive pathologic diagnoses. According to the pathological analysis of CNB, there were various benign lesions (58.9%, 73/124) besides recurrence, including benign postoperative lesions other than suture granuloma (32.3%, 40/124), suture granuloma (15.3%, 19/124), remnant thyroid tissue (5.6%, 7/124), parathyroid lesions (4%, 5/124), and abscesses (1.6%, 2/124). No major or minor complications were associated with the CNB procedure. Conclusion: US-guided CNB is accurate and safe for characterizing thyroidectomy bed lesions.

Relationship between 18F-FDG PET/CT Semi-Quantitative Parameters and International Association for the Study of Lung Cancer, American Thoracic Society/European Respiratory Society Classification in Lung Adenocarcinomas

  • Lihong Bu;NingTu;Ke Wang;Ying Zhou;Xinli Xie;Xingmin Han;Huiqin Lin;Hongyan Feng
    • Korean Journal of Radiology
    • /
    • 제23권1호
    • /
    • pp.112-123
    • /
    • 2022
  • Objective: To investigate the relationship between 18F-FDG PET/CT semi-quantitative parameters and the International Association for the Study of Lung Cancer, American Thoracic Society/European Respiratory Society (IASLC/ATS/ERS) histopathologic classification, including histological subtypes, proliferation activity, and somatic mutations. Materials and Methods: This retrospective study included 419 patients (150 males, 269 females; median age, 59.0 years; age range, 23.0-84.0 years) who had undergone surgical removal of stage IA-IIIA lung adenocarcinoma and had preoperative PET/CT data of lung tumors. The maximum standardized uptake values (SUVmax), background-subtracted volume (BSV), and background-subtracted lesion activity (BSL) derived from PET/CT were measured. The IASLC/ATS/ERS subtypes, Ki67 score, and epidermal growth factor/anaplastic lymphoma kinase (EGFR/ALK) mutation status were evaluated. The PET/CT semi-quantitative parameters were compared between the tumor subtypes using the Mann-Whitney U test or the Kruskal-Wallis test. The optimum cutoff values of the PET/CT semi-quantitative parameters for distinguishing the IASLC/ATS/ERS subtypes were calculated using receiver operating characteristic curve analysis. The correlation between the PET/CT semi-quantitative parameters and pathological parameters was analyzed using Spearman's correlation. Statistical significance was set at p < 0.05. Results: SUVmax, BSV, and BSL values were significantly higher in invasive adenocarcinoma (IA) than in minimally IA (MIA), and the values were higher in MIA than in adenocarcinoma in situ (AIS) (all p < 0.05). Remarkably, an SUVmax of 0.90 and a BSL of 3.62 were shown to be the optimal cutoff values for differentiating MIA from AIS, manifesting as pure ground-glass nodules with 100% sensitivity and specificity. Metabolic-volumetric parameters (BSV and BSL) were better potential independent factors than metabolic parameters (SUVmax) in differentiating growth patterns. SUVmax and BSL, rather than BSV, were strongly or moderately correlated with Ki67 in most subtypes, except for the micropapillary and solid predominant groups. PET/CT parameters were not correlated with EGFR/ALK mutation status. Conclusion: As noninvasive surrogates, preoperative PET/CT semi-quantitative parameters could imply IASLC/ATS/ERS subtypes and Ki67 index and thus may contribute to improved management of precise surgery and postoperative adjuvant therapy.

SonazoidTM versus SonoVue® for Diagnosing Hepatocellular Carcinoma Using Contrast-Enhanced Ultrasound in At-Risk Individuals: A Prospective, Single-Center, Intraindividual, Noninferiority Study

  • Hyo-Jin Kang;Jeong Min Lee;Jeong Hee Yoon;Jeongin Yoo;Yunhee Choi;Ijin Joo;Joon Koo Han
    • Korean Journal of Radiology
    • /
    • 제23권11호
    • /
    • pp.1067-1077
    • /
    • 2022
  • Objective: To determine whether Sonazoid-enhanced ultrasound (SZUS) was noninferior to SonoVue-enhanced ultrasound (SVUS) in diagnosing hepatocellular carcinoma (HCC) using the same diagnostic criteria. Materials and Methods: This prospective, single-center, noninferiority study (NCT04847726) enrolled 105 at-risk participants (71 male; mean age ± standard deviation, 63 ± 11 years; range, 26-86 years) with treatment-naïve solid hepatic nodules (≥ 1 cm). All participants underwent same-day SZUS (experimental method) and SVUS (control method) for one representative nodule per participant. Images were interpreted by three readers (the operator and two independent readers). All malignancies were diagnosed histopathologically, while the benignity of other lesions was confirmed by follow-up stability or pathology. The primary endpoint was per-lesion diagnostic accuracy for HCC pooled across three readers using the conventional contrast-enhanced ultrasound diagnostic criteria, including arterial phase hyperenhancement followed by mild (assessed within 2 minutes after contrast injection) and late (≥ 60 seconds with a delay of 5 minutes) washout. The noninferiority delta was -10%p. Furthermore, different time delays were compared as washout criteria in SZUS, including delays of 2, 5, and > 10 minutes. Results: A total of 105 lesions (HCCs [n = 61], non-HCC malignancies [n = 19], and benign [n = 25]) were evaluated. Using the 5-minutes washout criterion, per-lesion accuracy of SZUS pooled across the three readers (72.4%; 95% confidence interval [CI], 64.1%-79.3%) was noninferior to that of SVUS (71.4%; 95% CI, 63.1%-78.6%), meeting the statistical criterion for non-inferiority (difference of 0.95%p; 95% CI, -3.8%p-5.7%p). The arterial phase hyperenhancement combined with the 5-minutes washout criterion showed the same sensitivity as that of the > 10-minutes criterion (59.0% vs. 59.0%, p = 0.989), and the specificities were not significantly different (90.9% vs. 86.4%, p = 0.072). Conclusion: SZUS was noninferior to SVUS for diagnosing HCC in at-risk patients using the same diagnostic criteria. No significant improvement in HCC diagnosis was observed by extending the washout time delay from 5 to 10 minutes.

Preoperative Prediction for Early Recurrence Can Be as Accurate as Postoperative Assessment in Single Hepatocellular Carcinoma Patients

  • Dong Ik Cha;Kyung Mi Jang;Seong Hyun Kim;Young Kon Kim;Honsoul Kim;Soo Hyun Ahn
    • Korean Journal of Radiology
    • /
    • 제21권4호
    • /
    • pp.402-412
    • /
    • 2020
  • Objective: To evaluate the performance of predicting early recurrence using preoperative factors only in comparison with using both pre-/postoperative factors. Materials and Methods: We retrospectively reviewed 549 patients who had undergone curative resection for single hepatcellular carcinoma (HCC) within Milan criteria. Multivariable analysis was performed to identify pre-/postoperative high-risk factors of early recurrence after hepatic resection for HCC. Two prediction models for early HCC recurrence determined by stepwise variable selection methods based on Akaike information criterion were built, either based on preoperative factors alone or both pre-/postoperative factors. Area under the curve (AUC) for each receiver operating characteristic curve of the two models was calculated, and the two curves were compared for non-inferiority testing. The predictive models of early HCC recurrence were internally validated by bootstrap resampling method. Results: Multivariable analysis on preoperative factors alone identified aspartate aminotransferase/platelet ratio index (OR, 1.632; 95% CI, 1.056-2.522; p = 0.027), tumor size (OR, 1.025; 95% CI, 0.002-1.049; p = 0.031), arterial rim enhancement of the tumor (OR, 2.350; 95% CI, 1.297-4.260; p = 0.005), and presence of nonhypervascular hepatobiliary hypointense nodules (OR, 1.983; 95% CI, 1.049-3.750; p = 0.035) on gadoxetic acid-enhanced magnetic resonance imaging as significant factors. After adding postoperative histopathologic factors, presence of microvascular invasion (OR, 1.868; 95% CI, 1.155-3.022; p = 0.011) became an additional significant factor, while tumor size became insignificant (p = 0.119). Comparison of the AUCs of the two models showed that the prediction model built on preoperative factors alone was not inferior to that including both pre-/postoperative factors {AUC for preoperative factors only, 0.673 (95% confidence interval [CI], 0.623-0.723) vs. AUC after adding postoperative factors, 0.691 (95% CI, 0.639-0.744); p = 0.0013}. Bootstrap resampling method showed that both the models were valid. Conclusion: Risk stratification solely based on preoperative imaging and laboratory factors was not inferior to that based on postoperative histopathologic risk factors in predicting early recurrence after curative resection in within Milan criteria single HCC patients.